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Abstract 
 
CYP17A1 is a key steroidogenic enzyme known to conduct several distinct chemical transformations on multiple 
substrates. In its hydroxylase activity, this enzyme adds a hydroxyl group at the 17α position of both 
pregnenolone and progesterone at approximately equal rates. However, the subsequent 17,20 carbon–carbon 
scission reaction displays variable substrate specificity in the numerous CYP17A1 isozymes operating in 
vertebrates, manifesting as different Kd and kcat values when presented with 17α-hydroxypregnenlone (OHPREG) 
versus 17α-hydroxyprogesterone (OHPROG). Here we show that the identity of the residue at position 202 in 
human CYP17A1, thought to form a hydrogen bond with the A-ring alcohol substituent on the pregnene- 
nucleus, is a key driver of this enzyme’s native preference for OHPREG. Replacement of asparagine 202 with 
serine completely reverses the preference of CYP17A1, more than doubling the rate of turnover of the OHPROG 
to androstenedione reaction and substantially decreasing the rate of formation of dehydroepiandrosterone 
from OHPREG. In a series of resonance Raman experiments, it was observed that, in contrast with the case for 
the wild-type protein, in the mutant the 17α alcohol of OHPROG tends to form a H-bond with the proximal 
rather than terminal oxygen of the oxy–ferrous complex. When OHPREG was a substrate, the mutant enzyme 
was found to have a H-bonding interaction with the proximal oxygen that is substantially weaker than that of 
the wild type. These results demonstrate that a single-point mutation in the active site pocket of CYP17A1, even 
when far from the heme, has profound effects on steroidogenic selectivity in androgen biosynthesis. 
P450 CYP17A1 (CYP17A1) is a steroidogenic enzyme of critical importance in the pathway leading to the 
formation of androgens (Figure 1). Primarily localized in tissues of the adrenal gland and sex organs, the 
multifunctional CYP17A1 catalyzes the 17α hydroxylation of pregnenolone and progesterone as well as the 
subsequent 17,20 carbon–carbon bond scission or “C–C lyase” that gives rise to dehydroepiandrosterone (DHEA) 
and androstenedione (AD).(1, 2) Though subsequent biological transformations are required to generate the 
potent androgen receptor agonists testosterone and dihydrotestosterone, the upstream lyase activity of 
CYP17A1 is the first committed step in their production. The importance of these androgens in the proliferation 
of prostate cancer, coupled with the disappointing performance of 5α-reductase inhibitors, has created intense 
interest in this enzyme, most notably resulting in the development and approval of the inhibitor, abiraterone 
acetate. A groundbreaking 2012 publication described the crystal structure of CYP17A1,(3) yet much regarding 
the nature of key substrate–protein interactions that drive the selectivity of CYP17A1 remains unknown. 
 
Figure 1. Structures of substrates and products of CYP17A1. 
Human CYP17A1 is known to exhibit a strong preference for hydroxypregnenolone (OHPREG) over 
hydroxyprogesterone (OHPROG) when catalyzing carbon–carbon scission chemistry, despite its ability to 
hydroxylate pregnenolone and progesterone at roughly equivalent rates.(4, 5) This roughly 50-fold difference in 
terms of kcat/Km favoring OHPREG drives steroidogenic flux in humans predominantly through the OHPREG to 
DHEA pathway. However, preference for the OHPREG substrate is not conserved across CYP17 isozymes 
operating in the vertebrata subphylum. Whereas some isozymes have the same substrate preference as human 
CYP17A1, others have no substrate preference and still others more favorably catalyze the OHPROG to AD 
reaction.(6, 7) Although detailed studies of the activity of CYP17 enzymes across a range of species are still a 
work in progress, the Usanov laboratory has carefully evaluated the activities of various vertebrate CYP17 
enzymes under identical conditions and classified their activities as favoring OHPREG or OHPROG or as having no 
preference(6) (Table 1). Insight into the origin of these discrete substrate preferences was finally provided in 
seminal work by the Scott laboratory in which the crystal structure of truncated human CYP17A1 was 
determined first in the presence of its inhibitor, abiraterone, as well as subsequent structures of the A105L 
CYP17A1 mutant in the presence of all four native substrates.(3, 8) In all cases, the pregnene- nucleus is 
perpendicular to the heme with its D-ring juxtaposed against the iron atom and the β-face of the steroid 
directed toward the I-helix. Importantly, the C-3 substituent (−OH or ═O) is generally positioned within 
hydrogen bonding distance of asparagine 202, which projects its side chain from the F-helix into the active site 
cavity. 
Table 1. Sequence Alignment of Various CYP17 Enzymes with Associated Turnover Numbers with OHPREG or 
OHPROG as a Substratea 
species sequence OHPREG OHPROG 
Homo sapiens LNVIQNY-N-EGIIDNL 1.4 NMb 
Bos taurus LKAIQNV-N-DGILEV 4.6 NMb 
Bos bison LKAIQNV-N-DGILEV 1.7 NMb 
Felis catus LKIIQNY-N-EGILKTL 0.3 NMb 
Cavia porcellus LVTIRRF-T-TGFVNS NMb 1.7 
Equus caballus LETMQNY-H-KGILE 10.5 27.1 
Rattus norvegicus LTAIKTF-T-EGIVDA 0.8 2.2 
Xenopus laevis FEEMLAY-S-KGIVDT 0.09 0.14 
aProduct formation is expressed in units of nanomoles per minute per nanomole of P450 as documented by Usanov et al.(6) 
bNot measured. 
 
Emerging evidence suggests that even small changes in the hydrogen bonding patterns at position 202, which is 
remote from the heme active center, can substantially impact the position of substrates near the active iron–
oxygen intermediate responsible for catalysis in a manner that may either facilitate or hinder product 
formation.(9) The choice between a keto or alcohol group at the C-3 position directs the 17α-OH group of the 
substrate to form a hydrogen bond (H-bond) to either the proximal (OHPREG) or distal (OHPROG) oxygen of the 
oxy complex that persists following the subsequent one-electron reduction that forms the peroxo–ferric 
intermediate.(10) This is an essential distinction owing to the mechanism employed by CYP17A1 in the 
formation of androgens. Among the steroidogenic P450s, CYP17A1 is believed to be unique in that the C–C lyase 
chemistry can be initiated not by the traditional ferryl–oxene species but by a nucleophilic attack on the C-20 
carbonyl by a reactive peroxo–ferric intermediate.(5, 10-13) The resultant peroxo hemiketal may then 
decompose to the androgen product and acetic acid. Importantly, this mechanism is dependent upon 
unencumbered access to C-20 by the distal oxygen of the peroxoanion. 
To determine the relevance of N202 in substrate specificity, sequence alignments were performed (Table 1), and 
the residue identity at position 202 was compared to substrate preference, in terms of the product formation 
rates of the various vertebrate CYP17 enzymes published previously by the Usanov group.(6) In the case of 
enzymes that favor OHPREG as a substrate, an asparagine residue is generally conserved. However, in enzymes 
with an alternate preference, a serine or threonine residue generally occupies this position. On the basis of side 
chain torsion or mobility in proteins containing N202, this residue can potentially donate a H-bond to the keto 
group of OHPROG or accept a H-bond from the alcohol C-3 substituent on OHPREG substrates, respectively 
(Figure 2A,B).(8) We hypothesize that the alcohol presented by serine and threonine residues would form a 
favorable interaction with the keto fragment presented by OHPROG (Figure 2D). Expanding on results from the 
Usanov group in which this subtle alteration in side chain identity substantially impacted product formation 
rates, we postulated that this alcohol would fail to form the H-bonding interaction with OHPREG or the requisite 
geometry to form such an interaction would orient the substrate unfavorably for catalysis (Figure 2C). 
 
Figure 2. Schematic of hydrogen bonding interactions between substrates and asparagine or serine 202. 
To explore the role of the residue at position 202, which is located far from the heme center, we generated the 
N202S mutant in human CYP17A1 with the thought that this would reverse the substrate specificity of this 
isozyme. We reasoned that the choice of serine versus threonine or histidine was least likely to result in a steric 
clash owing to the diminished side chain bulk relative to other residues observed in other CYP17 isozymes. We 
further hypothesized that such a mutation would alter the position of the substrate in the active site. Among 
other alterations in individual catalytic steps, loss of the H-bond accepting character of the asparagine residue 
that directs the 17α alcohol to hydrogen bond with the proximal oxygen in the oxy– and peroxo–ferric forms 
could now explicitly favor OHPROG as a substrate in the C–C lyase reaction. The resultant mutant of CYP17A1 
was expressed in high yield and purified to electrophoretic homogeneity prior to incorporation into Nanodiscs. 
The Nanodisc system consists of CYP17A1 embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) lipid bilayer encircled by a solubilizing amphipathic scaffold protein.(14-17) Use of this system permits 
interrogation of the full-length and membrane-bound CYP17A1 protein under essentially native but controlled 
conditions and has found wide use in the study of this and many other proteins.(18) 
Experimental Procedures 
Expression, Purification, and Nanodisc Incorporation of N202S CYP17A1 
The N202S mutant was generated using a codon-optimized full-length human wild-type CYP17A1 synthetic gene 
(DNA 2.0) in the pCWori plasmid. Mutagenesis was performed using iProof polymerase with primers obtained 
from Integrated DNA Technologies. Forward primers were 5′-
TGAATGTGATCCAGAATTACAGTGAGGGCATCATCGACAAT-3′. Reverse primers were 5′-
ATTGTCGATGATGCCCTCACTGTAATTCTGGATCACATTCA-3′. Sequencing was performed by ACGT Inc. Expression, 
purification, and Nanodisc incorporation for both wild-type and N202S CYP17A1 were performed as previously 
described.(9, 19) 
Substrate Binding Titrations 
Spectral dissociation constants were determined by the sequential addition of substrate dissolved in methanol 
to a cuvette containing 1.5 μM CYP17A1 in 100 mM potassium phosphate (pH 7.4) and 50 mM NaCl. Electronic 
absorption spectra were recorded from 350 to 800 nm in a Cary 300 spectrophotometer at 25 °C. Spectral 
dissociation constants were estimated by plotting the change in the peak to trough A390 – A420 difference spectra 
versus substrate concentration and fitting the resultant binding isotherm to the quadratic tight binding 
equation.(20) For each substrate/enzyme pair, titrations were performed in triplicate, and the percent high spin 
was calculated at each substrate concentration using a peak to trough extinction coefficient in the difference 
spectra (ε390–420) of 100 mM–1 cm–1.(21) The error is reported as ±1 standard deviation. 
Product Formation 
Rat cytochrome P450 oxidoreductase and cytochrome b5 were expressed and purified as described 
previously.(22, 23) These proteins were inserted into Nanodiscs containing wild-type or N202S CYP17A1 as 
described by Grinkova et al.(24) Product formation rates were determined under saturating concentrations (40 
μM) of OHPREG or OHPROG in 100 mM potassium phosphate buffer (pH 7.4) and 50 mM NaCl. Mixtures 
containing 0.2 nmol of wild-type or N202S CYP17A1 Nanodiscs, 0.8 nmol of cytochrome b5, and 0.8 nmol of 
cytochrome P450 oxidoreductase in 1.0 mL of buffer were warmed to 37 °C, and the reaction was initiated by 
addition of 400 nmol of NADPH. After 10 min, reactions were quenched by addition of 50 μL of 8.9 N H2SO4, and 
mixtures were flash-frozen in liquid N2 and stored at −80 °C. 
Methods for extraction and quantitation of the products have been described in detail elsewhere.(5, 13, 
25) Briefly, products were extracted with 1.5 mL of dichloromethane after addition of a progesterone internal 
standard and dried under a stream of N2. Products of the OHPROG to AD reaction were analyzed by reversed-
phase high-performance liquid chromatography after reconstitution in 100 μL of methanol. Separation was 
achieved using an ACE3 C18 column and a linear gradient beginning with a 5:5:90 methanol:acetonitrile:water 
ratio and ending with a 45:45:10 methanol:acetonitrile:water ratio. Mobile phases were supplemented with 
0.2% formic acid, and the product was observed optically at 240 nm. The DHEA product was analyzed on a FID-
equipped gas chromatograph fitted with a 30 m DB-17 capillary column as described previously.(13) 
Sample Preparation for Resonance Raman (rR) Spectroscopy 
Ferric rR samples contained 150 μM N202S CYP17A1 Nanodiscs in 100 mM potassium phosphate buffer (pH 7.4) 
with 15% (v/v) glycerol and 450 μM OHPREG or OHPROG. Oxy–ferrous samples contained 150 μM N202S 
CYP17A1 Nanodiscs in 100 mM potassium phosphate (pH 7.4), 250 mM NaCl, and 30% (v/v) distilled glycerol. 
OHPREG, OHPROG, PREG, or PROG was added to a final concentration of 450 μM. Samples were deoxygenated 
under argon and reduced with a 1.5-fold molar excess of sodium dithionite in the presence of 3.8 μM methyl 
viologen. Each sample was then chilled to −15 °C in a dry ice/ethanol bath and oxygenated by being bubbled 
with 16O2 or 18O2 for 5 s. Samples were immediately flash-frozen in liquid N2 and stored at 77 K. 
rR Sample Measurements 
Resonance Raman spectra of the oxy complexes were recorded using a Spex 1269 spectrometer attached to a 
Spec-10 liquid nitrogen-cooled detector with a 2048-pixel resolution (Princeton Instruments, Princeton, NJ). The 
emission line at 413.1 nm from a Kr+ laser was focused by a cylindrical lens on the sample that was immersed in 
liquid nitrogen during data collection. The rR data were measured using this 413.1 nm line from the Kr+ laser 
(Coherent Innova Sabre Ion Laser) and collected using back scattering (180°) geometry with the laser beam 
being focused by a cylindrical lens to form a line image on the frozen sample contained in 5 mm outside 
diameter NMR tubes (WG-5 ECONOMY, Wilmad). The NMR tubes were positioned into a homemade double-
walled quartz low-temperature cell filled with liquid nitrogen. The sample tubes were spun to avoid local 
heating. The laser power was adjusted to ≤1 mW. All measurements were performed at 77 K, and the total 
collection time was ∼3 h in the high-frequency region and ∼4 h in the low-frequency region. The slit width was 
set at 150 μm, and a 1200 g/mm grating was used. Spectra were calibrated with fenchone (Sigma-Aldrich, 
Milwaukee, WI) and processed with Grams/32 AI software (Galactic Industries, Salem, NH). 
Results and Discussion 
Substrate Binding and Product Formation of N202S CYP17A1 
In a first set of experiments, we characterized the stability and substrate binding properties of N202S CYP17A1 
using electronic absorption spectroscopy. Once incorporated into Nanodiscs, the mutant protein is exceptionally 
stable, showing nearly 100% P450 in the ferrous:CO form. Soret maxima were identical to those of the wild-type 
enzyme: 417 nm for the ferric substrate free form, 393 nm in the ferric substrate-bound state, and 408 nm when 
the protein is reduced to the ferrous state with sodium dithionite. Spectral dissociation constant (Ks) values for 
wild-type and N202S CYP17A1 were obtained by sequential additions to samples of the four native substrates 
from methanolic stocks while the change in spin state was being monitored. In the case of the wild-type 
enzyme, Ks values for both PREG and PROG were roughly equivalent at 66 ± 11 and 41 ± 2.5 nM, respectively. 
Values for OHPREG and OHPROG were higher for the lyase substrates, and notable differences in affinity were 
distinguishable for the 17-OH derivatives. For OHPREG, the Ks was measured to be 170 ± 15 nM, and for 
OHPROG, it was 550 ± 17 nM (Figure 3). 
 
Figure 3. Substrate binding isotherms of wild-type and N202S CYP17A1. Solid lines denote data for the wild-type 
enzyme and dashed lines data for N202S. 
When binding of hydroxylase substrates to the N202S enzyme was monitored, the results were significantly 
different from those observed for wild-type CYP17A1. Although PROG (Figure 3B) was largely unaffected by this 
mutation (Ks = 16 ± 4.1 nM), binding of PREG was significantly impaired with a calculated Ks of 380 ± 57 nM 
(Figure 3A). Notably, the substrate preference of the lyase substrates was reversed for the mutant protein 
relative to that of the wild type. In the case of OHPREG, the Ks increased by nearly an order of magnitude to 
1500 ± 88 nM (Figure 3C). On the other hand, OHPROG bound substantially more tightly to N202S than to the 
wild type with a Ks of 53 ± 12 nM (Figure 3D). These results support a key role for an interaction between the 
substrate C-3 substituent and the residue present at position 202. Because the only other polar groups on the 
substrate (the 17α-OH and C-20 carbonyl) are positioned near the heme and are not seen to form contacts with 
protein side chains in any available crystal structures,(8) specific favorable interactions between residue 202 and 
A-ring keto or alcohol groups are likely essential determinants in dictating binding affinity. 
Another important probe of interaction of the ligand with the enzyme is the extent to which the P450 is 
converted to the “high-spin” state as substrate binding displaces water as the sixth ligand of the heme 
iron.(21) In the case of the wild-type enzyme, binding of PREG resulted in essentially complete low- to high-spin 
conversion, while PROG stimulated only a 90% transition to the high-spin form. In contrast, for this set of 
substrates, experiments with the N202S mutant exhibited behavior that was the opposite of that of the wild 
type: PREG binding resulted in a 92% shift to the high-spin state, while PROG binding saw a complete transition 
(panels A and B of Figure 3, respectively). In the case of lyase substrates, the wild-type enzyme again exhibited a 
more complete spin shift for substrates presenting a C-3 alcohol. For OHPREG and OHPROG, conversion to the 
high-spin state was 86% and 79%, respectively. Again, for the N202S mutant, the effects of substrates were 
reversed versus those of the wild type: OHPREG induced an 83% shift to the high-spin state, while OHPROG now 
caused an 88% conversion (panels C and D of Figure 3, respectively). Expulsion of water as a ligand to the heme 
iron is highly sensitive to the presence and orientation of the substrate in the distal active site pocket. Therefore, 
these results offer evidence that subtle differences in interactions between A-ring substituents and the residue 
at position 202 are reliably translated as differences in positioning of the D-ring near the heme. 
Next, we determined the role of N202 mutations in the function of CYP17A1. Steady state turnover rates for 
both wild-type and mutant enzymes were measured in parallel using saturating concentrations of OHPREG or 
OHPROG in the presence of a 4-fold molar excess of cytochrome b5 and cytochrome P450 oxidoreductase 
relative to CYP17A1. Interestingly, we found that substitution of N202 with a serine residue not only reversed 
binding affinity and spin state conversion but also had a significant impact on the product formation rates for 
the lyase reaction (Figure 4). As expected, formation of DHEA by the N202S mutant was impaired (0.12 min–1) 
relative to that by the wild type (0.41 min–1). However, the product formation rate of AD more than doubled for 
the mutant protein relative to that for the wild type, increasing from 0.20 to 0.49 min–1. These differences in the 
rate of enzyme turnover are unrelated to the changes in binding affinity, as all experiments were performed in 
the presence of saturating substrate concentrations. Rather, differences in product formation rates in the 
mutant protein are likely reflective of the substrate adopting an orientation more favorable for catalysis in the 
case of OHPROG, or less favorable in the case of OHPREG as revealed by rR spectroscopy. 
 
Figure 4. Steady state turnover of WT and N202S CYP17A1. Error bars represent ±1 standard deviation. 
Resonance Raman Spectroscopy of the Oxy–Ferrous Form of N202S CYP17A1 
In a previous study, we successfully documented a unique pattern of hydrogen bonding in which the 17-OH of 
the substrate forms a direct H-bond to the distal oxygen of the oxy–ferrous complex when OHPROG is a 
substrate, and the proximal oxygen atom when OHPREG is a substrate.(9) This hydrogen bonding pattern was 
found to persist in the subsequent peroxo–ferric species,(10)leaving the distal oxygen free to initiate a 
nucleophilic attack on the substrate C-20 carbonyl when OHPREG was a substrate. To explore the subtle changes 
in substrate orientation caused by the N202S mutation, we used rR spectroscopy to examine the nature of H-
bonding interactions between the substrate 17-OH and iron-bound dioxygen. The rR spectra of ND:CYP17A1 
N202S samples containing PROG and PREG substrates are identical and exhibit clear ν(Fe–O) and ν(O–O) 
stretching modes at 535 and 1139 cm–1, respectively (Figure 5, traces A and B). The 16O2 – 18O2 isotopic shifts are 
as expected,(26-28) i.e., 29 and 66 cm–1 for ν(Fe–O) and ν(O–O) modes, respectively. It is noted that the spectral 
patterns of the PROG- and PREG-bound mutant are almost identical to those of wild-type samples with 
corresponding substrates; i.e., the differences in frequencies are <1 cm–1 (Table 2). Differences in the orientation 
of these two substrates within the mutant active site do not substantially impact the Fe–O–O fragment because 
of the lack of a substrate-associated polar OH group within the immediate vicinity of the Fe–O–O fragment. 
 
Figure 5. 16O2 – 18O2 difference traces of the (A) PROG-, (B) PREG-, (C) OHPROG-, and (D) OHPREG-bound N202S 
mutant in the low-frequency (left) and high-frequency (right) regions. 
Table 2. Comparison of the ν(Fe–O) and ν(O–O) Modes for Wild-Type and N202S CYP17A1 
  ν(Fe–O) (cm–1) ν(O–O) (cm–1) ref 
PREG (WT) 535 1140 9 
OHPREG (WT) 526 1135 9 
Δwavenumber –9 –5 9 
PROG (WT) 536 1140 9 
OHPROG (WT) 542 1131 9 
Δwavenumber +6 –9 9 
PREG (N202S) 535 1139 – 
OHPREG (N202S) 530 1133 – 
Δwavenumber –5 –6 – 
PROG (N202S) 535 1139 – 
OHPROG (N202S) 530 1131 – 
Δwavenumber –5 –8 – 
 
As shown in Figure 5, high-quality rR spectra were also obtained for the dioxygen adducts of the samples bearing 
the hydroxylated substrates, OHPROG and OHPREG. The OHPROG sample exhibits ν(O–O) and ν(Fe–O) modes at 
1131 and 530 cm–1, respectively, with expected 16O2 – 18O2 isotopic shifts (65 and 29 cm–1, respectively). A similar 
spectral pattern is observed for the OHPREG-bound sample; the ν(O–O) stretching mode is observed at 1133 
cm–1 (65 cm–1 downshift upon 18O2 substitution), and the ν(Fe–O) mode is observed at 530 cm–1, where 
the 16O2 – 18O2 difference is 29 cm–1. 
Referring to Figure 5 and Table 2, which reports rR spectral data for the O2adducts of the wild type and N202S 
mutant, we emphasize that no significant changes in the internal modes of the Fe–O–O fragment were seen for 
the nonpolar PROG and PREG substrates; e.g., the ν(Fe–O) modes are seen at ∼535 cm–1, and the ν(O–O) modes 
are observed at ∼1140 cm–1 for the WT and N202 mutant containing PROG and PREG substrates. On the other 
hand, the spectra acquired for the N202S samples containing OHPROG and OHPREG are significantly different 
from the data acquired for the WT protein, with the changes mostly localized on the ν(Fe–O) vibrations. Thus, all 
four samples containing hydroxylated substrates, including WT and N202S mutant proteins, exhibit a ν(O–O) 
mode shifted by 5–9 cm–1 [Δwavenumber (Table 2)] from its position for the nonhydroxylated substrates, 
behavior that is consistent with the introduction of a new H-bonding residue in the vicinity of the Fe–O–O 
fragment. 
Most importantly, the variations of the ν(Fe–O) modes in response to the two different hydroxylated substrates, 
OHPROG and OHPREG, are revealing. In a previous work(9) that focused on the WT protein, convincing 
arguments, supported by experimental(29-35) and computational(36) studies, were made to suggest that the C–
OH group of OHPROG interacts with the terminal oxygen (Ot) of the Fe–Op–Ot fragment, causing a significant 
shift of the ν(Fe–O) mode to a higher frequency (542 cm–1), relative to the values observed for the nonpolar 
substrates. Conversely, the C–OH group of OHPREG interacts with the proximal (Op) oxygen atom of the Fe–Op–
Ot fragment, causing a shift of the ν(Fe–O) to a substantially lower frequency (526 cm–1). 
Important for this work is the fact that the apparent substrate repositioning caused by the N202S mutation 
drastically alters the resultant interactions of the substrate-associated OH groups with the Op and Ot atoms of 
the Fe–Op–Otfragment, as is evident from the observed shifts of the ν(Fe–O) modes. The ν(Fe–O) mode in the 
mutant sample containing OHPROG is observed at a frequency 12 cm–1 lower than that of the ν(Fe–O) mode in 
the OHPROG-bound WT sample (530 cm–1 in N202S vs 542 cm–1 in the WT). Conversely, the ν(Fe–O) mode of the 
OHPREG sample is 4 cm–1 higher in the mutant than it is in the WT sample (530 cm–1 in N202S vs 526 cm–1 in the 
WT) (Table 2 and Figure 6). 
 
Figure 6. Alteration of the pattern of bonding of hydrogen of wild-type and N202S CYP17A1 to the heme-bound 
dioxygen. The Fe–O wavenumber is indicated on the abscissa. 
While it is possible that the alteration of ν(Fe–O) stretching frequencies in the P450 samples with hydroxylated 
substrates might arise from electrostatic or structural changes on the proximal side of the heme pocket, such 
changes are usually reflected in changes in Fe–S bond strength. For instance, it was shown previously(37) that 
the alteration of polar interaction among anionic reductase, putidaredoxin, and the positively charged proximal 
side of the CYP101 led to a 3 cm–1 upshift of the ν(Fe–S) mode. Enhanced electron donation through a π-bonding 
interaction between a sulfur p orbital and the Fe dπ orbital resulted in significant strengthening of the Fe–S 
bond. However, measurements of N202S samples containing ferric OHPROG or OHPREG substrate using UV 
excitation revealed that the ν(Fe–S) stretching mode is observed at 347 cm–1 in the spectra of both samples 
(data not shown). This observation is consistent with the lack of a substrate effect on Fe–S bond strength in the 
WT protein, where the ν(Fe–S) stretching mode was also observed at 347 cm–1 in the presence of each of the 
four substrates.(38) This lack of changes in the ν(Fe–S) mode among all studied samples effectively argues that 
the proximal factors are negligible and that the observed changes in ν(Fe–O) modes arise only from the distal 
side effects, i.e., hydrogen bonding interactions with the Fe–O–O fragment. 
One reasonable interpretation of these shifts is that the downshift of the ν(Fe–O) mode in the mutant sample 
with OHPROG reflects a shift in the H-bonding interaction of the C–OH group from the Ot atom to the Op atom of 
the Fe–O–O fragment, though not to such a degree as was seen for the WT case with the OHPREG 
substrate.(9) Such a change in directionality of the H-bonding interaction is a clear indication that the positions 
of the OHPREG and OHPROG lyase substrates are mediated, at least in part, by interactions between the 
substrate C-3 substituent and the residue at position 202 in human CYP17A1. 
The discrete positioning of the substrate in the active site of a cytochrome P450 can have a profound impact on 
the catalytic efficiency of the enzyme. Because of the complexity of the P450 reaction cycle, there can be 
alterations in multiple steps. Interaction of the substrate with the distal water in the ferric low-spin complex can 
result in a significant modulation of the spin-state equilibrium with a corresponding impact on the ferric–ferrous 
redox potential and electron transfer rates. Structural changes that allow more or less water into the enzyme 
active site, with a resultant change in active site polarity, can also modulate the degree of coupling of pyridine 
nucleotide reducing equivalents to the product. Overall positioning relative to the heme-bound “active oxygen”, 
either a Compound I or peroxoanion, is of obvious importance to product formation. In all likelihood, multiple 
structural and dynamic factors may be involved. 
It is interesting, however, to link the observed changes in hydrogen bonding between the 17-OH groups of these 
steroids with results suggesting the involvement of the peroxoanion intermediate in the initiation of the carbon–
carbon bond scission event. In previous work,(13) we utilized kinetic solvent isotope effects (KSIEs) to document 
the nature of a peroxoanion intermediate as a critical branching point in lyase catalysis. Observation of an 
unusual inverse KSIE suggested a reactivity of the peroxoanion before protonation leading to O–O bond scission 
and formation of the Compound I metal–oxo intermediate that is active in normal hydroxylation chemistry. 
Rather, nucleophilic attack of the distal oxygen of the peroxo anion on the C-20 carbonyl would yield a 
hemiketal intermediate that was trapped at low temperatures.(10) Previous publications also used resonance 
Raman spectroscopy to monitor the differential hydrogen bonding patterns between the 17-OH group of 
OHPREG and OHPROG and the proximal and distal oxygen atoms in the ferrous dioxygen intermediate and 
showed that these patterns persist as the peroxoanion is formed.(9, 10) The results presented here document 
how substrate repositioning due to interactions at the A-ring can modulate the bonding of hydrogen to the 
heme-bound oxy–ferrous complex and thus contribute to a mechanistic understanding. 
If the mechanism of lyase activity involves the peroxoanion as we and others have suggested,(10, 11, 13) then 
the observed increase in the level of bonding of hydrogen to Op would be expected to free the terminal oxygen 
Ot to initiate a nucleophilic attack on the C-20 carbonyl, thus potentially increasing the lyase activity of the 
N202S mutant of OHPROG as compared to that of the wild type. 
Such an interpretation is supported by the product formation data reported herein, which show a 2-fold higher 
level of production of AD from OHPROG by the N202S mutant than by the wild type. On the other hand, the 
upshift of the ν(Fe–O) mode in the mutant sample containing OHPREG reflects a weakening of the bonding of 
hydrogen to Op, relative to that of the WT protein (Figure 6). This interpretation is also supported by the product 
formation studies, which show that the level of production of DHEA from OHPREG in the mutant is 
approximately 25% of that observed for the WT sample. 
From another perspective, it is noted that the rR spectral patterns of dioxygen adducts of the mutant in the 
presence of both hydroxylated substrates are consistent with virtually identical H-bonding interactions with the 
Fe–Op–Otfragment, both being mildly poised for peroxo attack on C-20,(9, 10) yet the product formation rate of 
the OHPROG sample (0.49 min–1) is 4 times higher than that of the OHPREG-bound sample (0.12 min–1). This 
observation leads to the conclusion that, while H-bonding interactions can play a significant role in controlling 
activity, when they are apparently equivalent, other factors certainly influence the overall enzymatic activity. 
In addition to other confounding complexities in the P450 reaction cycle mentioned previously, we also note 
that the discrepancy between the magnitude of the change in ν(Fe–O) modes and product formation rates in WT 
versus N202S may also be attributable to the absence of reductase and cytochrome b5 in our rR samples. As 
noted, the Fe–O–O fragment is especially susceptible to the strength and orientation of distal pocket H-bonding 
interactions.(36) There is ample precedent to suggest that binding of the redox partner to an oxy adduct of a 
cytochrome P450 (CYP101 and CYP11A1) can alter H-bonding interactions with the Fe–O–O fragments.(39, 
40) These considerations suggest that further, more elaborate, and technically demanding rR spectroscopic 
studies are required to fully clarify the nature of H-bonding interactions with the Fe–O–O fragments of these 
enzymes in the presence of redox partners. 
In conclusion, these spectroscopic and functional studies provide convincing evidence that the N202 residue of 
CYP17A1 plays a critical role in defining not only the affinity for either OHPREG or OHPROG but also the 
orientation of these hydroxylated substrates in the active site. These results demonstrate that minute changes 
resulting from a single-point mutation in the hydrogen bonding environment in the active site cavity, even when 
distant from the heme catalytic center, are capable of modulating this enzyme’s lyase activity. Notably, these 
results highlight the ability of this single residue to fine-tune the activity of CYP17A1 to adjust to the unique 
steroidogenic needs of various species. 
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